Screener
Oric Pharmaceuticals, Inc. ORIC Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The source filing: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204047
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| General and administrative | 8,182 | 8,078 |
| Total operating expenses | 39,619 | 32,718 |
| Loss from operations | (39,619) | (32,718) |
| Other income, net | 3,852 | 2,697 |
| Net loss | $(35,767) | $(30,021) |
| Other comprehensive loss: | ||
| Unrealized loss on investments | (1,076) | (170) |
| Comprehensive loss | $(36,843) | $(30,191) |
Item 1. Financial Statements.
FAQ
- What is Oric Pharmaceuticals, Inc.'s other income (expense)?
- Oric Pharmaceuticals, Inc. (ORIC) reported other income (expense) of $3.85M in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s other income (expense) changed year-over-year?
- Oric Pharmaceuticals, Inc.'s other income (expense) increased by 42.8% year-over-year, from $2.7M to $3.85M.
- What is the long-term trend for Oric Pharmaceuticals, Inc.'s other income (expense)?
- Over 4 years (2021 to 2025), Oric Pharmaceuticals, Inc.'s other income (expense) has grown at a 205.2% compound annual growth rate (CAGR), from $156K to $13.54M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about Oric Pharmaceuticals, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude